Inventor · disambiguated record
Carolyn S. Wei
Also filed as: WEI CAROLYN · WEI CAROLYN S
4 granted patents·4 pending applications·0 citations·filing 2014–2023
54Inventor score
Top patents by PatentIndex Score
8 records- 0159US11591314B2Process for preparing tetrahydrocarbazole carboxamide compoundBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Feb 28, 2023·0 cites·4 claims
- 0258US2025129050A1Synthesis of a kif18a inhibitorAMGEN INC·Filed 2023·Application pending·0 cites
- 0354US10875843B2Process for preparing tetrahydrocarbazole carboxamide compoundBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Dec 29, 2020·0 cites·6 claims
- 0453US12378246B2Synthetic options towards the manufacture of (6R,10S)-10-{4-[5-chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-6-oxo-1(6H)-pyrimidinyl} - 1-(difluoromethyl)-6-methyl-1,4,7,8,9,10-hexahydro-11,15-(metheno)pyrazolo[4,3-b][1,7]diazacyclotetradecin-5(6H)-oneBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Aug 5, 2025·0 cites·13 claims
- 0553US2024360147A1Process for Synthesizing Naphthyridine Derivatives and Intermediates ThereofAMGEN INC·Filed 2022·Application pending·0 cites
- 0648US2016022675A1Processes for preparing tetrahydroisoquinolinesBRISTOL MYERS SQUIBB CO·Filed 2014·Application pending·0 cites
- 0748US2023416252A1Process toward the manufacture of (6r,10s)-10-{4-[5-chloro-2-(4-chloro-1h-1,2,3-triazol-1-yl)phenyl]-6-oxo-1(6h)-pyrimidinyl}- 1-(difluoromethyl)-6-methyl-1,4,7,8,9,10-hexahydro-11,15-(metheno)pyrazolo[4,3-b][1,7]diazacyclotetradecin-5(6h)-oneBRISTOL MYERS SQUIBB CO·Filed 2021·Application pending·0 cites
- 0843US9518058B2Process for the preparation of N,N-dicyclopropyl-4-(1,5-dimethyl-1H-pyrazol-3-ylamino)-6-ethyl-1-methyl-1,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridine-7-carboxamideBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Dec 13, 2016·0 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when Carolyn S. Wei files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →